Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ⅲ Study of Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer by Nadroparin

NCT01980849 is registered in ClinicalTrials.gov with Shengqing Li as lead sponsor.

NCT NCT01980849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01980849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ⅲ Study of Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer by Nadroparin
Lead sponsor
Shengqing Li
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2013
Completion date
Not reported
Enrollment
272 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer